ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 91 filers reported holding ENDOCYTE INC in Q1 2018. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $14,170,000 | +31.2% | 797,888 | +2.0% | 0.00% | 0.0% |
| Q2 2018 | $10,797,000 | +816.6% | 782,447 | +503.6% | 0.00% | – |
| Q1 2018 | $1,178,000 | +240.5% | 129,626 | +60.3% | 0.00% | – |
| Q4 2017 | $346,000 | +208.9% | 80,856 | +2.3% | 0.00% | – |
| Q3 2017 | $112,000 | -5.9% | 79,036 | -0.0% | 0.00% | – |
| Q2 2017 | $119,000 | -88.3% | 79,039 | -80.0% | 0.00% | – |
| Q1 2017 | $1,018,000 | +1.1% | 396,048 | +0.3% | 0.00% | – |
| Q4 2016 | $1,007,000 | -14.6% | 394,770 | +3.4% | 0.00% | – |
| Q3 2016 | $1,179,000 | -3.4% | 381,662 | +0.4% | 0.00% | – |
| Q2 2016 | $1,220,000 | +9.3% | 380,059 | +5.6% | 0.00% | – |
| Q1 2016 | $1,116,000 | -22.3% | 359,853 | +0.4% | 0.00% | – |
| Q4 2015 | $1,436,000 | -13.4% | 358,255 | -1.0% | 0.00% | -100.0% |
| Q3 2015 | $1,658,000 | -22.7% | 362,001 | -12.4% | 0.00% | 0.0% |
| Q2 2015 | $2,144,000 | -12.9% | 413,047 | +5.1% | 0.00% | 0.0% |
| Q1 2015 | $2,461,000 | -0.8% | 393,156 | -0.4% | 0.00% | 0.0% |
| Q4 2014 | $2,482,000 | -0.4% | 394,694 | -3.7% | 0.00% | 0.0% |
| Q3 2014 | $2,492,000 | -6.4% | 409,944 | +1.4% | 0.00% | 0.0% |
| Q2 2014 | $2,663,000 | -72.6% | 404,097 | -0.9% | 0.00% | -66.7% |
| Q1 2014 | $9,712,000 | +105.6% | 407,867 | -7.8% | 0.00% | +50.0% |
| Q4 2013 | $4,723,000 | -18.3% | 442,185 | +2.0% | 0.00% | 0.0% |
| Q3 2013 | $5,779,000 | +5.2% | 433,497 | +3.6% | 0.00% | 0.0% |
| Q2 2013 | $5,493,000 | – | 418,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|